Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,235
Total Claims
$1.1M
Drug Cost
617
Beneficiaries
$1,847
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-96%
Opioid rate vs peers
0.1% vs 2.2% avg
+31%
Cost per patient vs peers
$1,847 vs $1,411 avg
+52%
Brand preference vs peers
16.1% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
16
Opioid Claims
$339
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,608 claims · $793K
Generic: 13,583 claims · $341K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 574 | $203K |
| Insulin Glargine,hum.Rec.Anlog | 101 | $36K |
| Rivaroxaban | 81 | $32K |
| Lipase/Protease/Amylase | 24 | $30K |
| Mirabegron | 111 | $27K |
| Sevelamer Hcl | 41 | $24K |
| Empagliflozin | 63 | $21K |
| Brexpiprazole | 29 | $19K |
| Atorvastatin Calcium | 1,045 | $16K |
| Budesonide/Formoterol Fumarate | 37 | $16K |
| Fluticasone/Vilanterol | 35 | $15K |
| Sitagliptin Phosphate | 44 | $13K |
| Pantoprazole Sodium | 540 | $13K |
| Insulin Lispro | 42 | $12K |
| Rsv Vacc, Pref A And Pref B/Pf | 36 | $12K |
Prescribing Profile
Patient Profile
79
Avg Age
65%
Female
3.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data